Long-term outcomes and treatment cessation in patients with long term response to first line treatment of metastatic prostate cancer.
Background and objectiveApproximately one third of men with metastatic prostate cancer die from causes other than prostate cancer. Little is known about the long-term outcomes of men with metastatic prostate cancer, in particular those who do not develop androgen pathway resistance. The objective of...
| Publicado en: | Oncologist pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |